The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas-Feasibility of a Novel Neurocognitive...

Neurocognitive testing in neuro-oncological patients often relies on time-intensive batteries with limited feasibility in this patient cohort. We evaluated the feasibility of the Bonn Leistungs Tracking Test (BLTT), a time-efficient screening tool assessing episodic memory, semantic memory, and executive functions in patients with high-grade temporal lobe gliomas.

Twenty patients undergoing resection of temporal high-grade glioma between 2019 and 2022 underwent preoperative cognitive assessment using either the BLTT or a comprehensive neuropsychological battery routinely applied in temporal lobe epilepsy surgery.

Twelve patients (60%) underwent the BLTT, and eight (40%) underwent the standard neuropsychological test battery. The BLTT was feasible in all 12 individuals (0% drop-out), whereas only four of eight patients (50% drop-out) were able to complete the standard battery. The mean BLTT total score was 69.3 (SD 4.5), indicating impaired neurocognitive performance relative to normative data. The BLTT provided evaluable domain-specific measures across episodic memory, semantic memory, and executive functioning despite the high discontinuation rate observed with standard testing.

The BLTT showed high feasibility for preoperative neurocognitive testing in patients with temporal high-grade gliomas. Its brief administration time and consistent applicability across relevant cognitive domains support its utility for routine neurocognitive assessment.